

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 4.86366642 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.74918209 |
| 3 | thrombin receptor signaling pathway (GO:0070493) | 4.30976426 |
| 4 | positive regulation of mast cell activation (GO:0033005) | 3.90759778 |
| 5 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.73889917 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.71540796 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.69481756 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.69481756 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.69481756 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 3.69481756 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 3.69481756 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 3.69481756 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.68203819 |
| 14 | negative regulation of cell killing (GO:0031342) | 3.68203819 |
| 15 | protein neddylation (GO:0045116) | 3.65134900 |
| 16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.63084326 |
| 17 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.56064261 |
| 18 | regulation of platelet aggregation (GO:0090330) | 3.55311659 |
| 19 | positive regulation of interferon-alpha production (GO:0032727) | 3.52810515 |
| 20 | leukocyte degranulation (GO:0043299) | 3.46014846 |
| 21 | neutrophil activation (GO:0042119) | 3.40423258 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.39280657 |
| 23 | response to peptidoglycan (GO:0032494) | 3.38405971 |
| 24 | regulation of platelet activation (GO:0010543) | 3.31681581 |
| 25 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.30620053 |
| 26 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.30407501 |
| 27 | hepatocyte apoptotic process (GO:0097284) | 3.30316933 |
| 28 | regulation of interferon-alpha production (GO:0032647) | 3.30190127 |
| 29 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.28794909 |
| 30 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.24903939 |
| 31 | detection of bacterium (GO:0016045) | 3.24072013 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 3.23672237 |
| 33 | B cell receptor signaling pathway (GO:0050853) | 3.20648326 |
| 34 | dendritic cell chemotaxis (GO:0002407) | 3.20525499 |
| 35 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.19675455 |
| 36 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.19675455 |
| 37 | granulocyte activation (GO:0036230) | 3.16927045 |
| 38 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.12720479 |
| 39 | regulation of regulatory T cell differentiation (GO:0045589) | 3.10267809 |
| 40 | positive regulation of mast cell degranulation (GO:0043306) | 3.09201908 |
| 41 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.09201908 |
| 42 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.08124191 |
| 43 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.05997692 |
| 44 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.03992435 |
| 45 | positive regulation of macrophage differentiation (GO:0045651) | 3.02811212 |
| 46 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.02021522 |
| 47 | respiratory burst (GO:0045730) | 2.96740988 |
| 48 | immunoglobulin mediated immune response (GO:0016064) | 2.95249051 |
| 49 | positive regulation of granulocyte differentiation (GO:0030854) | 2.95064201 |
| 50 | megakaryocyte development (GO:0035855) | 2.92472133 |
| 51 | negative regulation of interleukin-12 production (GO:0032695) | 2.89411155 |
| 52 | negative regulation of T cell apoptotic process (GO:0070233) | 2.86184741 |
| 53 | cytidine metabolic process (GO:0046087) | 2.82861025 |
| 54 | cytidine catabolic process (GO:0006216) | 2.82861025 |
| 55 | cytidine deamination (GO:0009972) | 2.82861025 |
| 56 | pinocytosis (GO:0006907) | 2.82119510 |
| 57 | T-helper 1 type immune response (GO:0042088) | 2.81505544 |
| 58 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.80217685 |
| 59 | superoxide anion generation (GO:0042554) | 2.78623577 |
| 60 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.78554482 |
| 61 | positive regulation of interferon-beta production (GO:0032728) | 2.76873039 |
| 62 | mast cell activation (GO:0045576) | 2.76481524 |
| 63 | regulation of RIG-I signaling pathway (GO:0039535) | 2.75975939 |
| 64 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.73217770 |
| 65 | actin nucleation (GO:0045010) | 2.72467079 |
| 66 | platelet aggregation (GO:0070527) | 2.71242781 |
| 67 | response to interferon-beta (GO:0035456) | 2.67212214 |
| 68 | negative T cell selection (GO:0043383) | 2.66601179 |
| 69 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.66208074 |
| 70 | positive regulation of B cell mediated immunity (GO:0002714) | 2.66208074 |
| 71 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.65929385 |
| 72 | myeloid dendritic cell activation (GO:0001773) | 2.65865665 |
| 73 | negative thymic T cell selection (GO:0045060) | 2.65490739 |
| 74 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.65225439 |
| 75 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.64608589 |
| 76 | response to host immune response (GO:0052572) | 2.64608589 |
| 77 | histamine secretion (GO:0001821) | 2.64430196 |
| 78 | DNA deamination (GO:0045006) | 2.63293229 |
| 79 | positive regulation of isotype switching (GO:0045830) | 2.61885226 |
| 80 | positive regulation of antigen processing and presentation (GO:0002579) | 2.61796328 |
| 81 | macrophage activation involved in immune response (GO:0002281) | 2.60553171 |
| 82 | phagocytosis, engulfment (GO:0006911) | 2.60461229 |
| 83 | negative regulation of mast cell activation (GO:0033004) | 2.59812477 |
| 84 | response to interleukin-15 (GO:0070672) | 2.58670247 |
| 85 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.58011004 |
| 86 | cellular extravasation (GO:0045123) | 2.57993824 |
| 87 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.56827205 |
| 88 | autophagic vacuole fusion (GO:0000046) | 2.56396594 |
| 89 | detection of biotic stimulus (GO:0009595) | 2.55798989 |
| 90 | response to interferon-alpha (GO:0035455) | 2.55167858 |
| 91 | positive regulation of DNA recombination (GO:0045911) | 2.54831265 |
| 92 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.54228227 |
| 93 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.54027022 |
| 94 | T cell migration (GO:0072678) | 2.52590859 |
| 95 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.51754021 |
| 96 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.51725763 |
| 97 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.51206539 |
| 98 | regulation of memory T cell differentiation (GO:0043380) | 2.50828202 |
| 99 | detection of other organism (GO:0098543) | 2.50425180 |
| 100 | positive regulation of T cell migration (GO:2000406) | 2.49149260 |
| 101 | regulation of activation of Janus kinase activity (GO:0010533) | 2.49121478 |
| 102 | regulation of mast cell activation (GO:0033003) | 2.49117721 |
| 103 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.48901593 |
| 104 | natural killer cell mediated immunity (GO:0002228) | 2.46945976 |
| 105 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.46945976 |
| 106 | detection of molecule of bacterial origin (GO:0032490) | 2.46566225 |
| 107 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.46231776 |
| 108 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.45865230 |
| 109 | leukocyte aggregation (GO:0070486) | 2.45850424 |
| 110 | myeloid dendritic cell differentiation (GO:0043011) | 2.45495257 |
| 111 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.45492596 |
| 112 | B cell mediated immunity (GO:0019724) | 2.44870510 |
| 113 | regulation of mast cell degranulation (GO:0043304) | 2.44785469 |
| 114 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.43133253 |
| 115 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.43133142 |
| 116 | regulation of antigen processing and presentation (GO:0002577) | 2.42547490 |
| 117 | response to muramyl dipeptide (GO:0032495) | 2.42299098 |
| 118 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.42129087 |
| 119 | regulation of mononuclear cell migration (GO:0071675) | 2.40303540 |
| 120 | negative regulation of viral genome replication (GO:0045071) | 2.39653908 |
| 121 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.38570760 |
| 122 | defense response to protozoan (GO:0042832) | 2.36983493 |
| 123 | myeloid cell activation involved in immune response (GO:0002275) | 2.36197920 |
| 124 | microglial cell activation (GO:0001774) | 2.35902735 |
| 125 | regulation of T cell migration (GO:2000404) | 2.35766026 |
| 126 | response to host (GO:0075136) | 2.34848564 |
| 127 | response to host defenses (GO:0052200) | 2.34848564 |
| 128 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.34848564 |
| 129 | cellular response to type I interferon (GO:0071357) | 2.33511627 |
| 130 | type I interferon signaling pathway (GO:0060337) | 2.33511627 |
| 131 | cellular response to exogenous dsRNA (GO:0071360) | 2.33218285 |
| 132 | response to type I interferon (GO:0034340) | 2.33164872 |
| 133 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.31815801 |
| 134 | positive regulation of B cell differentiation (GO:0045579) | 2.31173533 |
| 135 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.31110070 |
| 136 | definitive hemopoiesis (GO:0060216) | 2.31070939 |
| 137 | positive regulation of lymphocyte migration (GO:2000403) | 2.30624780 |
| 138 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.29693437 |
| 139 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.29657798 |
| 140 | positive regulation of T cell chemotaxis (GO:0010820) | 2.29565316 |
| 141 | regulation of T cell chemotaxis (GO:0010819) | 2.29565316 |
| 142 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.29241041 |
| 143 | macrophage activation (GO:0042116) | 2.27953552 |
| 144 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.27565478 |
| 145 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.26428360 |
| 146 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.25219776 |
| 147 | response to protozoan (GO:0001562) | 2.24843062 |
| 148 | neutrophil mediated immunity (GO:0002446) | 2.24235066 |
| 149 | myeloid leukocyte activation (GO:0002274) | 2.24120685 |
| 150 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.23138745 |
| 151 | regulation of metalloenzyme activity (GO:0048552) | 2.21841691 |
| 152 | glycosphingolipid catabolic process (GO:0046479) | 2.20699755 |
| 153 | positive regulation of interleukin-12 production (GO:0032735) | 2.20112751 |
| 154 | regulation of lymphocyte migration (GO:2000401) | 2.20033667 |
| 155 | cellular response to interferon-beta (GO:0035458) | 2.19311899 |
| 156 | regulation of B cell differentiation (GO:0045577) | 2.17827913 |
| 157 | platelet dense granule organization (GO:0060155) | 2.17370980 |
| 158 | lipoxygenase pathway (GO:0019372) | 2.17147641 |
| 159 | regulation of neutrophil migration (GO:1902622) | 2.15946442 |
| 160 | regulation of neutrophil chemotaxis (GO:0090022) | 2.15946442 |
| 161 | detection of external biotic stimulus (GO:0098581) | 2.15587987 |
| 162 | dendritic cell migration (GO:0036336) | 2.13521330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.98064139 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.78922785 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.60752855 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.43995469 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.31313827 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.23302004 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.86821444 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.68814620 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.66384340 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.59847350 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50811790 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.37571435 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37461080 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.33064839 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.30667162 |
| 16 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.24776310 |
| 17 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.20165769 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.19720269 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 2.19098959 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.18381536 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.91582940 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.91509946 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.88392927 |
| 24 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.87392701 |
| 25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.87292543 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.85406076 |
| 27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.83002523 |
| 28 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.81061875 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78985283 |
| 30 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.75855889 |
| 31 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.74694973 |
| 32 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.74290918 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.74179520 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.70090557 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.65009673 |
| 36 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.62747222 |
| 37 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.58845535 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53398204 |
| 39 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53223635 |
| 40 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.52831634 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47142841 |
| 42 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47076718 |
| 43 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44691319 |
| 44 | GATA1_19941826_ChIP-Seq_K562_Human | 1.44404004 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43595474 |
| 46 | * MYB_26560356_Chip-Seq_TH2_Human | 1.41118499 |
| 47 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.40787927 |
| 48 | GATA2_19941826_ChIP-Seq_K562_Human | 1.40286788 |
| 49 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.39342749 |
| 50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.37718889 |
| 51 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.36939844 |
| 52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.36894679 |
| 53 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.35224389 |
| 54 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.34796816 |
| 55 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.31605142 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30424474 |
| 57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28258267 |
| 58 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25918932 |
| 59 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.24710272 |
| 60 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24695062 |
| 61 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.24176229 |
| 62 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.22940511 |
| 63 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19824672 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18943855 |
| 65 | MYB_26560356_Chip-Seq_TH1_Human | 1.18908854 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17770822 |
| 67 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.17122080 |
| 68 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.16716983 |
| 69 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.16071409 |
| 70 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.15910404 |
| 71 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.15135193 |
| 72 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14847232 |
| 73 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.14465091 |
| 74 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13374128 |
| 75 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13046958 |
| 76 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12810213 |
| 77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11185721 |
| 78 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10917751 |
| 79 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10841265 |
| 80 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.10056295 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.09812098 |
| 82 | GATA3_26560356_Chip-Seq_TH2_Human | 1.07964127 |
| 83 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07371793 |
| 84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06616654 |
| 85 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.05855702 |
| 86 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.05151173 |
| 87 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03558928 |
| 88 | VDR_22108803_ChIP-Seq_LS180_Human | 1.02509357 |
| 89 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.02163813 |
| 90 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.01820723 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01116325 |
| 92 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.99819900 |
| 93 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.97927151 |
| 94 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97191064 |
| 95 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95935938 |
| 96 | GATA3_26560356_Chip-Seq_TH1_Human | 0.94616546 |
| 97 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.94219654 |
| 98 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.94054072 |
| 99 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93635195 |
| 100 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.92875034 |
| 101 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91981618 |
| 102 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.91535001 |
| 103 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91159536 |
| 104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91088317 |
| 105 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.90134254 |
| 106 | MAF_26560356_Chip-Seq_TH1_Human | 0.90101257 |
| 107 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.89936004 |
| 108 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89699456 |
| 109 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89241060 |
| 110 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.88998567 |
| 111 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.88163408 |
| 112 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86063874 |
| 113 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.86053245 |
| 114 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.85635127 |
| 115 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.85635127 |
| 116 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.85006861 |
| 117 | * STAT1_20625510_ChIP-Seq_HELA_Human | 0.84606132 |
| 118 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.84571749 |
| 119 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.84074800 |
| 120 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.81221605 |
| 121 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.79651083 |
| 122 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.79145329 |
| 123 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78542115 |
| 124 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.78490053 |
| 125 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.78142697 |
| 126 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.77285914 |
| 127 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.75358462 |
| 128 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.75297747 |
| 129 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.74907289 |
| 130 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.74478670 |
| 131 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74375194 |
| 132 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.74358710 |
| 133 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.73909442 |
| 134 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.73476010 |
| 135 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.72512172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.46540685 |
| 2 | MP0002148_abnormal_hypersensitivity_rea | 2.76215842 |
| 3 | MP0003436_decreased_susceptibility_to | 2.75993681 |
| 4 | MP0009785_altered_susceptibility_to | 2.75449923 |
| 5 | MP0003724_increased_susceptibility_to | 2.70128757 |
| 6 | MP0002419_abnormal_innate_immunity | 2.43199618 |
| 7 | MP0006082_CNS_inflammation | 2.25305300 |
| 8 | MP0008004_abnormal_stomach_pH | 2.24279897 |
| 9 | MP0005671_abnormal_response_to | 2.22417004 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.17612628 |
| 11 | MP0005025_abnormal_response_to | 2.12395803 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.01454523 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.00809749 |
| 14 | MP0001790_abnormal_immune_system | 1.85489256 |
| 15 | MP0005387_immune_system_phenotype | 1.85489256 |
| 16 | MP0002396_abnormal_hematopoietic_system | 1.83451235 |
| 17 | MP0001800_abnormal_humoral_immune | 1.80826134 |
| 18 | MP0002723_abnormal_immune_serum | 1.77391991 |
| 19 | MP0005058_abnormal_lysosome_morphology | 1.77090521 |
| 20 | MP0000343_altered_response_to | 1.76779277 |
| 21 | MP0000685_abnormal_immune_system | 1.75848412 |
| 22 | MP0001853_heart_inflammation | 1.73099972 |
| 23 | MP0001533_abnormal_skeleton_physiology | 1.72494276 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.70284951 |
| 25 | MP0001819_abnormal_immune_cell | 1.68897351 |
| 26 | MP0002420_abnormal_adaptive_immunity | 1.66772989 |
| 27 | MP0008438_abnormal_cutaneous_collagen | 1.60295478 |
| 28 | MP0006054_spinal_hemorrhage | 1.60250085 |
| 29 | MP0002405_respiratory_system_inflammati | 1.57472470 |
| 30 | MP0009764_decreased_sensitivity_to | 1.53266560 |
| 31 | MP0001545_abnormal_hematopoietic_system | 1.48860691 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.48860691 |
| 33 | MP0002933_joint_inflammation | 1.47144322 |
| 34 | MP0003828_pulmonary_edema | 1.46197896 |
| 35 | MP0003279_aneurysm | 1.43616639 |
| 36 | MP0002132_abnormal_respiratory_system | 1.43393395 |
| 37 | MP0003866_abnormal_defecation | 1.39292649 |
| 38 | MP0003186_abnormal_redox_activity | 1.38674788 |
| 39 | MP0009697_abnormal_copulation | 1.38036765 |
| 40 | MP0008057_abnormal_DNA_replication | 1.36583026 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.35644012 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.35217300 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.34228732 |
| 44 | MP0004808_abnormal_hematopoietic_stem | 1.30589926 |
| 45 | MP0000716_abnormal_immune_system | 1.27696071 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.26672041 |
| 47 | MP0003448_altered_tumor_morphology | 1.25960884 |
| 48 | MP0002398_abnormal_bone_marrow | 1.25686906 |
| 49 | MP0009278_abnormal_bone_marrow | 1.25664551 |
| 50 | MP0008469_abnormal_protein_level | 1.23991553 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.23680582 |
| 52 | MP0005084_abnormal_gallbladder_morpholo | 1.20892838 |
| 53 | MP0004883_abnormal_blood_vessel | 1.19347956 |
| 54 | MP0005390_skeleton_phenotype | 1.17841878 |
| 55 | MP0001879_abnormal_lymphatic_vessel | 1.17742503 |
| 56 | MP0004510_myositis | 1.17721332 |
| 57 | MP0002138_abnormal_hepatobiliary_system | 1.16881423 |
| 58 | MP0000689_abnormal_spleen_morphology | 1.15900816 |
| 59 | MP0002277_abnormal_respiratory_mucosa | 1.15534914 |
| 60 | MP0000767_abnormal_smooth_muscle | 1.13836780 |
| 61 | MP0002006_tumorigenesis | 1.13276156 |
| 62 | MP0000703_abnormal_thymus_morphology | 1.13195410 |
| 63 | MP0002429_abnormal_blood_cell | 1.13037442 |
| 64 | MP0003693_abnormal_embryo_hatching | 1.10456240 |
| 65 | MP0004084_abnormal_cardiac_muscle | 1.07415007 |
| 66 | MP0002722_abnormal_immune_system | 1.07028208 |
| 67 | MP0005083_abnormal_biliary_tract | 1.06671743 |
| 68 | MP0000490_abnormal_crypts_of | 1.06261879 |
| 69 | MP0002166_altered_tumor_susceptibility | 1.06210554 |
| 70 | MP0002998_abnormal_bone_remodeling | 1.04625999 |
| 71 | MP0003252_abnormal_bile_duct | 1.03611104 |
| 72 | MP0003075_altered_response_to | 1.03108587 |
| 73 | MP0008007_abnormal_cellular_replicative | 1.02863759 |
| 74 | MP0000858_altered_metastatic_potential | 1.02525911 |
| 75 | MP0005166_decreased_susceptibility_to | 1.00568965 |
| 76 | MP0004947_skin_inflammation | 1.00090011 |
| 77 | MP0001663_abnormal_digestive_system | 0.99498414 |
| 78 | MP0004782_abnormal_surfactant_physiolog | 0.98731198 |
| 79 | MP0003183_abnormal_peptide_metabolism | 0.97990244 |
| 80 | MP0000015_abnormal_ear_pigmentation | 0.96433893 |
| 81 | MP0001851_eye_inflammation | 0.95963949 |
| 82 | MP0003950_abnormal_plasma_membrane | 0.95842444 |
| 83 | MP0003566_abnormal_cell_adhesion | 0.95738734 |
| 84 | MP0005023_abnormal_wound_healing | 0.93991157 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 0.93590581 |
| 86 | MP0005085_abnormal_gallbladder_physiolo | 0.93059541 |
| 87 | MP0005165_increased_susceptibility_to | 0.92788514 |
| 88 | MP0010368_abnormal_lymphatic_system | 0.90324098 |
| 89 | MP0003077_abnormal_cell_cycle | 0.90135299 |
| 90 | MP0005075_abnormal_melanosome_morpholog | 0.90051830 |
| 91 | MP0009763_increased_sensitivity_to | 0.89895989 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 0.88075875 |
| 93 | MP0008058_abnormal_DNA_repair | 0.87446873 |
| 94 | MP0005503_abnormal_tendon_morphology | 0.87140975 |
| 95 | MP0000230_abnormal_systemic_arterial | 0.86378199 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.85782703 |
| 97 | MP0005164_abnormal_response_to | 0.85293492 |
| 98 | MP0008872_abnormal_physiological_respon | 0.85136618 |
| 99 | MP0003303_peritoneal_inflammation | 0.84866752 |
| 100 | MP0002877_abnormal_melanocyte_morpholog | 0.83791254 |
| 101 | MP0003763_abnormal_thymus_physiology | 0.83221357 |
| 102 | MP0000249_abnormal_blood_vessel | 0.82486328 |
| 103 | MP0001958_emphysema | 0.81699151 |
| 104 | MP0003795_abnormal_bone_structure | 0.81364132 |
| 105 | MP0010094_abnormal_chromosome_stability | 0.80235668 |
| 106 | MP0001915_intracranial_hemorrhage | 0.80014300 |
| 107 | MP0003718_maternal_effect | 0.79528984 |
| 108 | MP0005410_abnormal_fertilization | 0.79410189 |
| 109 | MP0003195_calcinosis | 0.78710009 |
| 110 | MP0005310_abnormal_salivary_gland | 0.78033900 |
| 111 | MP0004147_increased_porphyrin_level | 0.77919883 |
| 112 | MP0010307_abnormal_tumor_latency | 0.77009836 |
| 113 | MP0002019_abnormal_tumor_incidence | 0.75053595 |
| 114 | MP0009840_abnormal_foam_cell | 0.74292206 |
| 115 | MP0006036_abnormal_mitochondrial_physio | 0.73710606 |
| 116 | MP0003045_fibrosis | 0.73167769 |
| 117 | MP0004381_abnormal_hair_follicle | 0.72802727 |
| 118 | MP0005408_hypopigmentation | 0.72547758 |
| 119 | MP0004036_abnormal_muscle_relaxation | 0.72485111 |
| 120 | MP0005365_abnormal_bile_salt | 0.72461702 |
| 121 | MP0003943_abnormal_hepatobiliary_system | 0.72279175 |
| 122 | MP0008260_abnormal_autophagy | 0.71558755 |
| 123 | MP0003806_abnormal_nucleotide_metabolis | 0.71219273 |
| 124 | MP0004484_altered_response_of | 0.70910112 |
| 125 | MP0003638_abnormal_response/metabolism_ | 0.70078976 |
| 126 | MP0001243_abnormal_dermal_layer | 0.68600174 |
| 127 | MP0010352_gastrointestinal_tract_polyps | 0.66213280 |
| 128 | MP0005174_abnormal_tail_pigmentation | 0.65863745 |
| 129 | MP0001873_stomach_inflammation | 0.65167729 |
| 130 | MP0003172_abnormal_lysosome_physiology | 0.63967659 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.67150222 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.13223754 |
| 3 | Abnormal platelet volume (HP:0011876) | 4.96125204 |
| 4 | Menorrhagia (HP:0000132) | 4.91703239 |
| 5 | Increased mean platelet volume (HP:0011877) | 4.90500492 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.51680820 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.84094282 |
| 8 | Abnormality of macrophages (HP:0004311) | 3.61225514 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 3.49900633 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.49636644 |
| 11 | Abnormal platelet function (HP:0011869) | 3.37242570 |
| 12 | Impaired platelet aggregation (HP:0003540) | 3.37242570 |
| 13 | Autoimmune hemolytic anemia (HP:0001890) | 3.25757276 |
| 14 | Myositis (HP:0100614) | 3.12172398 |
| 15 | Recurrent skin infections (HP:0001581) | 3.06230496 |
| 16 | Orchitis (HP:0100796) | 3.05754277 |
| 17 | Petechiae (HP:0000967) | 3.04804349 |
| 18 | Conjunctival telangiectasia (HP:0000524) | 2.97048450 |
| 19 | T lymphocytopenia (HP:0005403) | 2.94866374 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 2.87830348 |
| 21 | Prostate neoplasm (HP:0100787) | 2.87460582 |
| 22 | Chest pain (HP:0100749) | 2.82166548 |
| 23 | Panhypogammaglobulinemia (HP:0003139) | 2.77960503 |
| 24 | Abnormality of T cells (HP:0002843) | 2.76345758 |
| 25 | Retrobulbar optic neuritis (HP:0100654) | 2.75013704 |
| 26 | Optic neuritis (HP:0100653) | 2.75013704 |
| 27 | Gastrointestinal infarctions (HP:0005244) | 2.72946291 |
| 28 | Irregular epiphyses (HP:0010582) | 2.72897247 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.72828401 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 2.72828401 |
| 31 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.70562825 |
| 32 | Systemic lupus erythematosus (HP:0002725) | 2.67389847 |
| 33 | Hemoptysis (HP:0002105) | 2.56995809 |
| 34 | Gingivitis (HP:0000230) | 2.54366264 |
| 35 | Pulmonary embolism (HP:0002204) | 2.53826312 |
| 36 | Abnormality of T cell physiology (HP:0011840) | 2.53328971 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 2.52846470 |
| 38 | Anorexia (HP:0002039) | 2.52524074 |
| 39 | Spontaneous hematomas (HP:0007420) | 2.51096587 |
| 40 | Osteolytic defects of the hand bones (HP:0009699) | 2.50563219 |
| 41 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.50563219 |
| 42 | Recurrent pneumonia (HP:0006532) | 2.48845658 |
| 43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.48237280 |
| 44 | Obstructive lung disease (HP:0006536) | 2.48237280 |
| 45 | Thick nail (HP:0001805) | 2.46120860 |
| 46 | Dyschromatopsia (HP:0007641) | 2.46047124 |
| 47 | Epiphyseal dysplasia (HP:0002656) | 2.45552419 |
| 48 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.44772545 |
| 49 | Poikilocytosis (HP:0004447) | 2.44584625 |
| 50 | Recurrent fungal infections (HP:0002841) | 2.42569687 |
| 51 | Agammaglobulinemia (HP:0004432) | 2.40073596 |
| 52 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.39990420 |
| 53 | Poor head control (HP:0002421) | 2.37620815 |
| 54 | Thrombophlebitis (HP:0004418) | 2.36478695 |
| 55 | Chronic diarrhea (HP:0002028) | 2.36320849 |
| 56 | Acanthocytosis (HP:0001927) | 2.35783386 |
| 57 | Hepatosplenomegaly (HP:0001433) | 2.34154615 |
| 58 | Autoimmune thrombocytopenia (HP:0001973) | 2.30568158 |
| 59 | Increased cerebral lipofuscin (HP:0011813) | 2.29779680 |
| 60 | Joint swelling (HP:0001386) | 2.29068813 |
| 61 | Agnosia (HP:0010524) | 2.28062698 |
| 62 | Pustule (HP:0200039) | 2.24979027 |
| 63 | Periodontitis (HP:0000704) | 2.24185537 |
| 64 | Gingival bleeding (HP:0000225) | 2.22676719 |
| 65 | Hematochezia (HP:0002573) | 2.21889722 |
| 66 | Mucosal telangiectasiae (HP:0100579) | 2.21777288 |
| 67 | Flat capital femoral epiphysis (HP:0003370) | 2.21612959 |
| 68 | Amaurosis fugax (HP:0100576) | 2.21308891 |
| 69 | Leukocytosis (HP:0001974) | 2.20045286 |
| 70 | Abnormality of iron homeostasis (HP:0011031) | 2.19591516 |
| 71 | Basal ganglia calcification (HP:0002135) | 2.18630802 |
| 72 | Recurrent viral infections (HP:0004429) | 2.18410687 |
| 73 | Inflammation of the large intestine (HP:0002037) | 2.18176669 |
| 74 | Hypergammaglobulinemia (HP:0010702) | 2.17097210 |
| 75 | Prolonged bleeding time (HP:0003010) | 2.16790131 |
| 76 | Abnormality of the prostate (HP:0008775) | 2.16470853 |
| 77 | Acute hepatic failure (HP:0006554) | 2.12773106 |
| 78 | Bruising susceptibility (HP:0000978) | 2.10462534 |
| 79 | Abnormality of the common coagulation pathway (HP:0010990) | 2.10454488 |
| 80 | IgG deficiency (HP:0004315) | 2.10348381 |
| 81 | Patchy hypopigmentation of hair (HP:0011365) | 2.10272381 |
| 82 | Purpura (HP:0000979) | 2.09994606 |
| 83 | Myocardial infarction (HP:0001658) | 2.08697470 |
| 84 | Urticaria (HP:0001025) | 2.08334563 |
| 85 | Stomatitis (HP:0010280) | 2.08333322 |
| 86 | Recurrent lower respiratory tract infections (HP:0002783) | 2.08077729 |
| 87 | Gangrene (HP:0100758) | 2.07511993 |
| 88 | Abnormal pupillary function (HP:0007686) | 2.07401006 |
| 89 | Reduced antithrombin III activity (HP:0001976) | 2.06996807 |
| 90 | Paralysis (HP:0003470) | 2.06746516 |
| 91 | Cellulitis (HP:0100658) | 2.06422914 |
| 92 | Episodic fever (HP:0001954) | 2.06135882 |
| 93 | Epistaxis (HP:0000421) | 2.05415174 |
| 94 | Polyneuropathy (HP:0001271) | 2.03178810 |
| 95 | Vasculitis (HP:0002633) | 2.03174767 |
| 96 | Spinal cord lesions (HP:0100561) | 2.02607655 |
| 97 | Syringomyelia (HP:0003396) | 2.02607655 |
| 98 | Nausea (HP:0002018) | 2.01439007 |
| 99 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.00989647 |
| 100 | Microcytic anemia (HP:0001935) | 2.00522912 |
| 101 | Vitreoretinal degeneration (HP:0000655) | 1.98865839 |
| 102 | Tinnitus (HP:0000360) | 1.98593698 |
| 103 | Thrombocytosis (HP:0001894) | 1.96026763 |
| 104 | IgM deficiency (HP:0002850) | 1.95064190 |
| 105 | Cupped ribs (HP:0000887) | 1.95062544 |
| 106 | Pulmonary fibrosis (HP:0002206) | 1.93532406 |
| 107 | Gastrointestinal inflammation (HP:0004386) | 1.93303448 |
| 108 | Small epiphyses (HP:0010585) | 1.93128304 |
| 109 | Vertigo (HP:0002321) | 1.93074106 |
| 110 | Osteomyelitis (HP:0002754) | 1.92298372 |
| 111 | Glomerulonephritis (HP:0000099) | 1.90848208 |
| 112 | Increased serum ferritin (HP:0003281) | 1.90381465 |
| 113 | Skin rash (HP:0000988) | 1.89764332 |
| 114 | White forelock (HP:0002211) | 1.88937054 |
| 115 | Spondylolisthesis (HP:0003302) | 1.87748644 |
| 116 | Granulocytopenia (HP:0001913) | 1.87017939 |
| 117 | Polycythemia (HP:0001901) | 1.86889780 |
| 118 | Eosinophilia (HP:0001880) | 1.86729996 |
| 119 | Prolonged neonatal jaundice (HP:0006579) | 1.85902953 |
| 120 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.85887580 |
| 121 | Beaking of vertebral bodies (HP:0004568) | 1.84862728 |
| 122 | Keratoconjunctivitis sicca (HP:0001097) | 1.81795875 |
| 123 | Cervical subluxation (HP:0003308) | 1.81362574 |
| 124 | Metaphyseal dysplasia (HP:0100255) | 1.80813509 |
| 125 | Birth length less than 3rd percentile (HP:0003561) | 1.78234618 |
| 126 | Increased IgM level (HP:0003496) | 1.77945682 |
| 127 | Vertebral compression fractures (HP:0002953) | 1.77762643 |
| 128 | Arterial thrombosis (HP:0004420) | 1.77297059 |
| 129 | Congenital, generalized hypertrichosis (HP:0004540) | 1.77111028 |
| 130 | Short middle phalanx of the 5th finger (HP:0004220) | 1.76736502 |
| 131 | Meningitis (HP:0001287) | 1.73918839 |
| 132 | Pulmonary infiltrates (HP:0002113) | 1.73915391 |
| 133 | Hypoplastic ischia (HP:0003175) | 1.73507715 |
| 134 | Acute myeloid leukemia (HP:0004808) | 1.73343648 |
| 135 | Encephalitis (HP:0002383) | 1.72138685 |
| 136 | Abnormality of T cell number (HP:0011839) | 1.71990504 |
| 137 | Abnormality of the lumbar spine (HP:0100712) | 1.71721478 |
| 138 | Abnormality of eosinophils (HP:0001879) | 1.71549136 |
| 139 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.71501249 |
| 140 | Abnormality of incisor morphology (HP:0011063) | 1.70011547 |
| 141 | Chronic otitis media (HP:0000389) | 1.69579754 |
| 142 | Axonal loss (HP:0003447) | 1.69259266 |
| 143 | Abnormal foot bone ossification (HP:0010675) | 1.69097032 |
| 144 | Chromsome breakage (HP:0040012) | 1.68215995 |
| 145 | Nonimmune hydrops fetalis (HP:0001790) | 1.67390274 |
| 146 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.66284230 |
| 147 | Joint hemorrhage (HP:0005261) | 1.65091386 |
| 148 | Interstitial pulmonary disease (HP:0006530) | 1.63668690 |
| 149 | Keratoconjunctivitis (HP:0001096) | 1.63043449 |
| 150 | Disinhibition (HP:0000734) | 1.62913435 |
| 151 | Anhidrosis (HP:0000970) | 1.62546887 |
| 152 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.61990997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 2.86976540 |
| 2 | MAP3K14 | 2.61973850 |
| 3 | NEK9 | 2.46273062 |
| 4 | IRAK3 | 2.40825322 |
| 5 | BLK | 2.39106096 |
| 6 | FES | 2.27331403 |
| 7 | TXK | 2.12365379 |
| 8 | PBK | 2.10763163 |
| 9 | TGFBR2 | 1.99182482 |
| 10 | NME2 | 1.87456555 |
| 11 | TEC | 1.86271620 |
| 12 | PIM2 | 1.84434786 |
| 13 | KIT | 1.77999051 |
| 14 | TIE1 | 1.77278462 |
| 15 | FGR | 1.76022042 |
| 16 | TYK2 | 1.74043673 |
| 17 | GRK6 | 1.73445432 |
| 18 | NUAK1 | 1.72146269 |
| 19 | TBK1 | 1.71382726 |
| 20 | MAP4K1 | 1.66776681 |
| 21 | RPS6KA4 | 1.66062425 |
| 22 | MAP2K3 | 1.61656253 |
| 23 | JAK3 | 1.61563166 |
| 24 | * IKBKB | 1.61365809 |
| 25 | TRPM7 | 1.58111171 |
| 26 | BTK | 1.54123974 |
| 27 | ZAK | 1.54050113 |
| 28 | MKNK1 | 1.53422761 |
| 29 | LMTK2 | 1.52460142 |
| 30 | STK16 | 1.52295068 |
| 31 | MAP3K3 | 1.51991992 |
| 32 | ACVR1B | 1.49543737 |
| 33 | TGFBR1 | 1.48432799 |
| 34 | KDR | 1.48051505 |
| 35 | BMPR1B | 1.47717359 |
| 36 | MST4 | 1.42110770 |
| 37 | EIF2AK1 | 1.40851279 |
| 38 | IKBKE | 1.40287627 |
| 39 | PTK2B | 1.38591750 |
| 40 | MAP3K12 | 1.36732800 |
| 41 | BUB1 | 1.36144489 |
| 42 | STK3 | 1.35542034 |
| 43 | STK10 | 1.35191519 |
| 44 | MUSK | 1.32178247 |
| 45 | CSF1R | 1.31785655 |
| 46 | BRSK2 | 1.29393567 |
| 47 | TAOK3 | 1.23275619 |
| 48 | EIF2AK3 | 1.21657849 |
| 49 | STK4 | 1.20782955 |
| 50 | PIM1 | 1.19003961 |
| 51 | ZAP70 | 1.16952906 |
| 52 | EIF2AK2 | 1.14669222 |
| 53 | BMX | 1.14314246 |
| 54 | PLK4 | 1.13619419 |
| 55 | ERBB3 | 1.10735458 |
| 56 | NLK | 1.09914629 |
| 57 | PRKCQ | 1.07196315 |
| 58 | SIK3 | 1.06914336 |
| 59 | TNK2 | 1.06388525 |
| 60 | CHUK | 1.05525800 |
| 61 | LYN | 0.99869159 |
| 62 | CSK | 0.96403115 |
| 63 | SRPK1 | 0.93558766 |
| 64 | NEK6 | 0.90375848 |
| 65 | EPHB1 | 0.89760277 |
| 66 | ERN1 | 0.88119020 |
| 67 | VRK1 | 0.84954902 |
| 68 | JAK1 | 0.84436120 |
| 69 | LATS1 | 0.82952454 |
| 70 | GRK5 | 0.80290706 |
| 71 | WEE1 | 0.76510923 |
| 72 | CLK1 | 0.76172625 |
| 73 | ADRBK2 | 0.75203330 |
| 74 | STK24 | 0.74667949 |
| 75 | ITK | 0.73755321 |
| 76 | MKNK2 | 0.73589915 |
| 77 | ABL2 | 0.71803883 |
| 78 | LCK | 0.70598045 |
| 79 | IRAK1 | 0.70426419 |
| 80 | EPHA3 | 0.69969883 |
| 81 | ILK | 0.69788278 |
| 82 | PIK3CA | 0.69509102 |
| 83 | PIK3CG | 0.68268509 |
| 84 | HCK | 0.66638323 |
| 85 | RPS6KA5 | 0.66441344 |
| 86 | TESK2 | 0.66021763 |
| 87 | MATK | 0.64623802 |
| 88 | TRIM28 | 0.64416085 |
| 89 | YES1 | 0.63242659 |
| 90 | GRK1 | 0.62817595 |
| 91 | FRK | 0.62676916 |
| 92 | FER | 0.62648619 |
| 93 | SYK | 0.62362999 |
| 94 | CDK6 | 0.60041094 |
| 95 | DYRK3 | 0.59613834 |
| 96 | MYLK | 0.59255180 |
| 97 | MAP3K5 | 0.59200242 |
| 98 | FLT3 | 0.58403829 |
| 99 | ABL1 | 0.57275095 |
| 100 | ATR | 0.57032696 |
| 101 | MAP3K13 | 0.56589501 |
| 102 | PDK1 | 0.55814870 |
| 103 | PAK1 | 0.54693531 |
| 104 | PAK4 | 0.54089813 |
| 105 | CDK7 | 0.53658796 |
| 106 | MAPKAPK5 | 0.52878754 |
| 107 | MAPKAPK3 | 0.52098622 |
| 108 | AURKB | 0.51195748 |
| 109 | BMPR2 | 0.50413555 |
| 110 | MARK3 | 0.50393419 |
| 111 | OXSR1 | 0.49103308 |
| 112 | FGFR3 | 0.48940147 |
| 113 | PDK2 | 0.47392809 |
| 114 | MAPKAPK2 | 0.45631538 |
| 115 | LRRK2 | 0.45044891 |
| 116 | ADRBK1 | 0.44269900 |
| 117 | PRKG2 | 0.42087362 |
| 118 | TLK1 | 0.41907588 |
| 119 | PRKCD | 0.41895561 |
| 120 | IGF1R | 0.39855422 |
| 121 | MAP3K1 | 0.39402823 |
| 122 | EGFR | 0.39173114 |
| 123 | GRK7 | 0.39164271 |
| 124 | RIPK4 | 0.38889915 |
| 125 | OBSCN | 0.35554310 |
| 126 | IRAK2 | 0.34555016 |
| 127 | BRD4 | 0.34544216 |
| 128 | JAK2 | 0.34002195 |
| 129 | FYN | 0.33705225 |
| 130 | PRKD1 | 0.32526877 |
| 131 | MAPK12 | 0.30760842 |
| 132 | PLK2 | 0.29415125 |
| 133 | MAP3K2 | 0.28420843 |
| 134 | PDPK1 | 0.27541379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.67695876 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.43959129 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.32914784 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.29633257 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.12972510 |
| 6 | Malaria_Homo sapiens_hsa05144 | 2.07725355 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 1.92079333 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 1.83181407 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.82147094 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.80374951 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.79366741 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.67740007 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63439163 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.62461737 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.58448959 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.55414862 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.54847071 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.54431256 |
| 19 | Proteasome_Homo sapiens_hsa03050 | 1.51322364 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.47727543 |
| 21 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.43996460 |
| 22 | DNA replication_Homo sapiens_hsa03030 | 1.43985328 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.40702240 |
| 24 | Homologous recombination_Homo sapiens_hsa03440 | 1.40433141 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.40397649 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.39410666 |
| 27 | RNA polymerase_Homo sapiens_hsa03020 | 1.35602573 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.34983915 |
| 29 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.33716776 |
| 30 | Protein export_Homo sapiens_hsa03060 | 1.33150019 |
| 31 | Basal transcription factors_Homo sapiens_hsa03022 | 1.28816556 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.26467545 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.25969928 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.21895352 |
| 35 | Base excision repair_Homo sapiens_hsa03410 | 1.18387439 |
| 36 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.17635368 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.17067315 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.17009665 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.16541206 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.15362522 |
| 41 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.14970947 |
| 42 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.14053075 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13766541 |
| 44 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.13757253 |
| 45 | Mismatch repair_Homo sapiens_hsa03430 | 1.12005292 |
| 46 | Ribosome_Homo sapiens_hsa03010 | 1.11520357 |
| 47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.10895521 |
| 48 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.10446680 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.09432722 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.04658869 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.03477371 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.02679413 |
| 53 | Apoptosis_Homo sapiens_hsa04210 | 0.99731154 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99397352 |
| 55 | Cell cycle_Homo sapiens_hsa04110 | 0.96270051 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 0.96230332 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96067869 |
| 58 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.95851839 |
| 59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.95585176 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.95526981 |
| 61 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.95283405 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.94073996 |
| 63 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.92033634 |
| 64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.91511034 |
| 65 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90684592 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.89760908 |
| 67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88849057 |
| 68 | Salmonella infection_Homo sapiens_hsa05132 | 0.86505633 |
| 69 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.86087403 |
| 70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82709237 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.82290443 |
| 72 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.81789530 |
| 73 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.80755520 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79855648 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79220488 |
| 76 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.78584927 |
| 77 | Hepatitis B_Homo sapiens_hsa05161 | 0.75493991 |
| 78 | RNA degradation_Homo sapiens_hsa03018 | 0.75134323 |
| 79 | * SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72402757 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71392531 |
| 81 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71383850 |
| 82 | Spliceosome_Homo sapiens_hsa03040 | 0.70834642 |
| 83 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.70471173 |
| 84 | RNA transport_Homo sapiens_hsa03013 | 0.69796887 |
| 85 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68142102 |
| 86 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.66651270 |
| 87 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66034368 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.65783918 |
| 89 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.63972685 |
| 90 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.63915256 |
| 91 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61042827 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.60238001 |
| 93 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.59869723 |
| 94 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59861347 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59735137 |
| 96 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58912603 |
| 97 | * Platelet activation_Homo sapiens_hsa04611 | 0.57786382 |
| 98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57554850 |
| 99 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55980527 |
| 100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54901693 |
| 101 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.53073872 |
| 102 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52463924 |
| 103 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52359866 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.52161225 |
| 105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45093226 |
| 106 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.44684844 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42346271 |
| 108 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.42171538 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42047472 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41526283 |
| 111 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.40088472 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39747233 |
| 113 | Histidine metabolism_Homo sapiens_hsa00340 | 0.39458402 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38981341 |
| 115 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38787491 |
| 116 | Adherens junction_Homo sapiens_hsa04520 | 0.38092887 |
| 117 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.37987854 |
| 118 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.37162700 |
| 119 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35187466 |
| 120 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.34897051 |
| 121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34357949 |
| 122 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.30412225 |
| 123 | Peroxisome_Homo sapiens_hsa04146 | 0.29977451 |
| 124 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29066528 |
| 125 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.28534015 |
| 126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27630620 |
| 127 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.26189200 |
| 128 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.23413336 |
| 129 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.23383883 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22075506 |
| 131 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.18002901 |
| 132 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.17874569 |

